JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3551
Hurco Companies Inc
HURC
$146M
| $698K | ﹤0.01% |
24,946
-45,972
| -65% | -$1.35M |
2013 Q2
28 quarters
|
|
3552
Insteel Industries
IIIN
$585M
| $698K | ﹤0.01% |
36,626
+23,161
| +172% | +$391K |
2016 Q4
14 quarters
|
|
3553
LCNB Corp
LCNB
$271M
| $697K | ﹤0.01% |
43,715
-5,127
| -10% | -$70.6K |
2017 Q4
10 quarters
|
|
|
BSCO
3554
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
| $695K | ﹤0.01% |
31,529
+16,578
| +111% | +$358K |
2019 Q3
3 quarters
|
|
|
SWTX
3555
DELISTED
SpringWorks Therapeutics
SWTX
| $694K | ﹤0.01% |
16,514
+13,076
| +380% | +$465K |
2019 Q4
2 quarters
|
|
3556
Citizens & Northern Corp
CZNC
$459M
| $692K | ﹤0.01% |
33,547
-6,161
| -16% | -$116K |
2013 Q2
28 quarters
|
|
3557
CALL
M/I Homes
MHO
$3.36B
| $689K | ﹤0.01% |
+20,000
| New | +$547K |
2020 Q2
0 quarters
|
|
3558
Tucows
TCX
$102M
| $688K | ﹤0.01% |
11,989
+6,039
| +101% | +$335K |
2017 Q4
10 quarters
|
|
3559
Viemed Healthcare
VMD
$352M
| $687K | ﹤0.01% |
+71,554
| New | +$556K |
2020 Q2
0 quarters
|
|
|
HT
3560
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $686K | ﹤0.01% |
119,113
-337,385
| -74% | -$1.8M |
2013 Q2
28 quarters
|
|
3561
Celestica
CLS
$48.1B
| $685K | ﹤0.01% |
100,363
-62,253
| -38% | -$356K |
2020 Q1
1 quarter
|
|
|
VRN
3562
DELISTED
Veren
VRN
| $685K | ﹤0.01% |
420,266
+409,751
| +3,897% | +$566K |
2014 Q1
25 quarters
|
|
3563
CALL
Acadia Healthcare
ACHC
$2.68B
| $683K | ﹤0.01% |
+27,200
| New | +$679K |
2020 Q2
0 quarters
|
|
3564
Allegiant Air
ALGT
$2.13B
| $683K | ﹤0.01% |
6,264
-80,305
| -93% | -$7.34M |
2015 Q1
21 quarters
|
|
3565
CALL
Heron Therapeutics
HRTX
$64.5M
| $683K | ﹤0.01% |
+46,400
| New | +$762K |
2020 Q2
0 quarters
|
|
|
AMAG
3566
DELISTED
AMAG Pharmaceuticals
AMAG
| $683K | ﹤0.01% |
89,213
-3,457
| -4% | -$26.5K |
2013 Q2
28 quarters
|
|
|
MCBC
3567
DELISTED
Macatawa Bank Corp
MCBC
| $682K | ﹤0.01% |
87,177
-30,245
| -26% | -$219K |
2015 Q4
18 quarters
|
|
3568
Graham Corp
GHM
$1.07B
| $679K | ﹤0.01% |
53,333
-60,758
| -53% | -$742K |
2015 Q4
18 quarters
|
|
3569
PUT
Tencent Music
TME
$12.8B
| $673K | ﹤0.01% |
50,000
| – | – |
2020 Q1
1 quarter
|
|
3570
CALL
EOG Resources
EOG
$75.8B
| $669K | ﹤0.01% |
13,200
+3,200
| +32% | +$155K |
2016 Q2
16 quarters
|
|
|
YARW
3571
Yarrow Bioscience
YARW
$166M
| $667K | ﹤0.01% |
107
-7
| -6% | -$47.4K |
2018 Q1
9 quarters
|
|
3572
Gorman-Rupp
GRC
$2.06B
| $666K | ﹤0.01% |
21,431
-5,627
| -21% | -$165K |
2015 Q4
18 quarters
|
|
3573
iShares Global Clean Energy ETF
ICLN
$2.28B
| $663K | ﹤0.01% |
52,985
-2,500
| -5% | -$28.1K |
2016 Q4
14 quarters
|
|
3574
iShares Global Energy ETF
IXC
$3.06B
| $661K | ﹤0.01% |
33,827
-268
| -0.8% | -$5.23K |
2013 Q2
28 quarters
|
|
3575
Digi International
DGII
$2.87B
| $660K | ﹤0.01% |
56,712
-9,533
| -14% | -$102K |
2015 Q1
21 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.